Last Update 04 May 26
Fair value Decreased 2.08%RKT: Future Returns Will Hinge On Dividend Growth And Share Buybacks
Reckitt Benckiser Group's analyst price target has been trimmed by about £1.32 per share, as analysts factor in softer revenue growth and profit margin assumptions alongside a slightly higher future P/E multiple.
Analyst Commentary
Recent research on Reckitt Benckiser points to a mixed set of views, with some analysts trimming price targets while others are upgrading their stance. The focus is squarely on how the company can execute against its plans and what investors are paying for that execution.
Bullish Takeaways
- Bullish analysts who have upgraded the stock highlight a more constructive view on execution, suggesting the company could be better placed to deliver on its operational plans than previously assumed.
- Where price targets have been maintained or upgraded, the argument leans on the current P/E looking reasonable relative to perceived earnings power, even with more conservative assumptions now embedded in some models.
- Supportive research implies that, despite sector headwinds, the company still has identifiable drivers that could support earnings resilience, which some analysts see as underappreciated in the current valuation.
- Positive rating changes signal that a portion of the market views recent share price and estimate resets as having already accounted for several execution risks.
Bearish Takeaways
- Bearish analysts have lowered price targets in the £54.60 to £62.00 range in GBp terms. This reflects more cautious assumptions on revenue growth and margins and a view that the prior valuation left limited room for disappointment.
- Several target cuts point to concern that profit margins could be slower to recover than previously expected, which weighs on earnings forecasts and, in turn, the price investors may be willing to pay.
- The clustering of lower targets from large institutions suggests a segment of the market is more focused on execution risk, particularly around cost control and reinvestment needs, than on potential upside scenarios.
- Where targets have been reduced, the signal for investors is that some analysts see risk of further estimate adjustments if the company does not deliver cleanly on its current guidance and operational goals.
What's in the News
- The U.S. International Trade Commission has started an investigation into certain over the counter topical lidocaine patches tied to alleged patent infringement, with Reckitt Benckiser Group plc and related entities among multiple respondents. Potential outcomes include limited exclusion orders and cease and desist orders if violations are found (U.S. International Trade Commission notice).
- The Board of Directors is proposing a final 2025 dividend of 127.8 pence per share, which would bring the full year 2025 dividend to 212.2 pence per share. This is described as up 5.0% versus the 2024 full year dividend of 202.1 pence per share, subject to shareholder approval (company board proposal).
- For 2026, the company has provided earnings guidance that points to like for like net revenue growth in Core Reckitt within a medium term guidance range of +4% to +5% (company guidance statement).
- Between 28 July 2025 and 31 December 2025, the company repurchased 7,381,913 shares, described as 1.13% of its share base, for a total of £425.3m. This completed the buyback announced on 28 July 2025 (company buyback update).
Valuation Changes
- Fair Value: modelled fair value per share has been trimmed from £63.61 to £62.29, a reduction of about £1.32.
- Discount Rate: the discount rate is unchanged at 7.198%, indicating the same required rate of return is being applied in the updated assumptions.
- Revenue Growth: long-term revenue growth assumptions have been revised from a 0.60% decline to a 0.99% decline, implying a more cautious view on future £ revenue trends.
- Net Profit Margin: projected net profit margin has been adjusted from 17.58% to 17.18%, a modest reduction in expected profitability.
- Future P/E: the assumed future P/E multiple has moved slightly higher from 19.99x to 20.28x, indicating a small uplift in the valuation multiple being used.
Key Takeaways
- Expansion in emerging markets and ongoing product innovation are fueling higher margins and positioning Reckitt for sustained, above-market revenue growth.
- Strategic cost reductions and portfolio optimization are enabling increased investment in key brands, supporting further market share gains and earnings resilience.
- Legal risks, stagnating developed market growth, powerbrand concentration, rising competition, and execution risk on cost-saving measures threaten profit trajectory and margin improvement.
Catalysts
About Reckitt Benckiser Group- Manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally.
- Strong double-digit revenue and margin growth in emerging markets is being driven by expanding middle class consumption and increasing digital penetration, particularly in India and China; these markets are likely to remain Reckitt's main growth engine, supporting sustained group revenue and margin expansion.
- Consistent innovation and premiumization of core brands, including launching plant-derived and first-to-market products and expanding into underpenetrated segments, is enabling Reckitt to command higher prices and capture new volumes, which should drive both top-line growth and higher net margins.
- The company's strategic focus on health, hygiene, and nutrition-categories with resilient long-term demand, including rising global health and hygiene awareness-positions Reckitt to benefit from ongoing sector tailwinds, supporting above-market, recurring revenue growth.
- The Fuel for Growth program is delivering fixed cost reductions and operational simplification ahead of plan, enabling greater reinvestment into brand marketing and innovation, which will likely create a virtuous cycle for further market share gains and improved earnings quality.
- Portfolio optimization through divestment of slower-growth, lower-margin businesses allows management to reallocate resources into faster-growing, higher-margin powerbrands, further enhancing overall net margins and earnings resilience.
Reckitt Benckiser Group Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Reckitt Benckiser Group's revenue will remain fairly flat over the next 3 years.
- Analysts assume that profit margins will shrink from 22.5% today to 17.2% in 3 years time.
- Analysts expect earnings to reach £2.4 billion (and earnings per share of £3.8) by about May 2029, down from £3.2 billion today. The analysts are largely in agreement about this estimate.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 20.3x on those 2029 earnings, up from 9.4x today. This future PE is greater than the current PE for the GB Household Products industry at 9.3x.
- Analysts expect the number of shares outstanding to decline by 1.01% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 7.2%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Ongoing legal risks, specifically significant litigation related to product safety and infant formula in the US, could result in substantial legal costs, settlements, or fines, placing continuing pressure on net margins and overall earnings progression.
- Exposure to slower or stagnating category and volume growth in developed markets (Europe and North America), combined with ongoing uncertainty in consumer demand, puts a cap on organic revenue gains and makes Reckitt increasingly reliant on emerging markets for growth.
- Dependence on a concentrated portfolio of Powerbrands (e.g., Dettol, Lysol, Durex, Mucinex), heightens vulnerability to category-specific disruptions, shifts in consumer preferences, or product controversy, which could disproportionately impact overall revenue and profit trajectory.
- Intensifying competitive and channel dynamics, including the proliferation of private label brands in e-commerce (Amazon, Walmart) and rising promotional activity in both developed and emerging markets, could constrain Reckitt's pricing power and compress both revenue growth and margins.
- Continued execution risk in the Fuel for Growth cost-savings and restructuring initiatives (organizational simplification, shared services roll-out, digital/AI optimization), where failure to achieve targets or significant stranded costs from divestitures (like Essential Home) could undermine planned margin expansion and earnings improvement.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of £62.29 for Reckitt Benckiser Group based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of £75.0, and the most bearish reporting a price target of just £51.79.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be £13.8 billion, earnings will come to £2.4 billion, and it would be trading on a PE ratio of 20.3x, assuming you use a discount rate of 7.2%.
- Given the current share price of £47.13, the analyst price target of £62.29 is 24.3% higher. Despite analysts expecting the underlying business to decline, they seem to believe it's more valuable than what the market thinks.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Reckitt Benckiser Group?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.